Be part of a global study to see whether an investigational medication can decrease the chance of HIV transmission through sexual contact.
About the Study
PURPOSE 2 is a clinical research drug trial evaluating Lenacapavir, an investigational medicine designed to reduce the chance of getting HIV through sex. Some participants who enroll in the study will receive the investigation drug, Lenacapavir, via injection every 6 months while the other participants will receive the FDA-approved oral medication Truvada. Study-related doctors’ visits, condition monitoring, and the study medicine will be provided to participants at no cost. You do not need health insurance to participate. To see if you qualify for this trial, complete the prescreening form below.
To be eligible for this study you must be:
- At least 18 years old
- Having sex with male partners
- At risk for HIV
- Unaware of HIV status
- Not currently taking PrEP
No Cost Treatment
Make an Impact
Complete this form to see if you qualify to participate in the Purpose 2 clinical trial. The information you provide is confidential and will be used only to determine your eligibility in this trial. Your information will not be shared.